Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.73 |
| ▸ | TSHR | P16473 | 2/20 | 0.73 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.73 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.73 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.73 |
| ▸ | RAB9A | P51151 | 1/20 | 0.73 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.73 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | CTSK | P43235 | 8/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CTSL | P07711 | 2/20 | 0.31 |
| ▸ | CTSS | P25774 | 2/20 | 0.31 |
| ▸ | CTSB | P07858 | 1/20 | 0.31 |
| ▸ | CTSH | P09668 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29464244 | 0.92 | LMNA (0.85) | LMNATSHRCYP3A4NFKB1ADRA1A | |
| SCHEMBL13415141 | 0.88 | TSHR (0.57) | LMNATSHRCYP3A4NFKB1ADRA1A | |
| SCHEMBL27745846 | 0.87 | LMNA (0.59) | LMNATSHRCYP3A4NFKB1ADRA1A | |
| Carisoprodol SCHEMBL2232476 | 0.84 | TSHR (1.00) | LMNATSHRCYP3A4NFKB1ADRA1A | |
| Carisoprodol SCHEMBL158375 | 0.84 | TSHR (1.00) | LMNATSHRCYP3A4NFKB1ADRA1A | |
| Carisoprodol SCHEMBL33286 | 0.84 | TSHR (1.00) | LMNATSHRCYP3A4NFKB1ADRA1A | |
| Carisoprodol SCHEMBL8379174 | 0.84 | TSHR (1.00) | LMNATSHRCYP3A4NFKB1ADRA1A | |
| Carisoprodol SCHEMBL23856096 | 0.83 | TSHR (0.97) | LMNATSHRCYP3A4NFKB1ADRA1A | |
| Carisoprodol SCHEMBL10448685 | 0.83 | TSHR (0.97) | LMNATSHRCYP3A4NFKB1ADRA1A | |
| Carisoprodol SCHEMBL21633327 | 0.83 | TSHR (0.97) | LMNATSHRCYP3A4NFKB1ADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103641744-B | The synthetic method of carisoprodol intermediate compound | SHANDONG XINQUAN PHARMACEUTICAL CO., LTD. (CN) | 2016-02-24 | — | — | CN | claimed |
| EP-2418492-B1 | Immunoreagent for meprobamate | RANDOX LABORATORIES LTD (GB) | 2018-10-10 | — | — | EP | disclosed |
| CN-103641744-B | The synthetic method of carisoprodol intermediate compound | SHANDONG XINQUAN PHARMACEUTICAL CO., LTD. (CN) | 2016-02-24 | — | — | CN | disclosed |
| CN-103641744-A | Synthesis method of carisoprodol intermediate compound | SHANDONG XINQUAN PHARMACEUTICAL CO LTD | 2014-03-19 | — | — | CN | disclosed |
| CN-102531965-A | Synthesis method for carisoprodol | SHANDONG XINQUAN MEDICINE CO LTD | 2012-07-04 | — | — | CN | disclosed |
| US-20120040378-A1 | Meprobromate Immunoassay | RANDOX LABORATORIES LIMITED (GB) | 2012-02-16 | — | — | US | disclosed |
| US-20120040378-A1 | Meprobromate Immunoassay | RANDOX LABORATORIES LIMITED (GB) | 2012-02-16 | — | — | US | disclosed |
| EP-2418492-A1 | Meprobamate immunoassay | Randox Laboratories Ltd. (GB) | 2012-02-15 | — | — | EP | disclosed |
| EP-2418492-A1 | Meprobamate immunoassay | Randox Laboratories Ltd. (GB) | 2012-02-15 | — | — | EP | disclosed |
| US-20100076074-A1 | CARBAMATE REDUCERS OF SKELETAL MUSCLE TENSION | AUSPEX PHARMACEUTICALS, INC. (US) | 2010-03-25 | — | — | US | disclosed |
| US-20100076074-A1 | CARBAMATE REDUCERS OF SKELETAL MUSCLE TENSION | AUSPEX PHARMACEUTICALS, INC. (US) | 2010-03-25 | — | — | US | disclosed |
| US-20100076074-A1 | CARBAMATE REDUCERS OF SKELETAL MUSCLE TENSION | AUSPEX PHARMACEUTICALS, INC. (US) | 2010-03-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100076074-A1 | CARBAMATE REDUCERS OF SKELETAL MUSCLE TENSION | TNNC1, MUSK, MYLK2 | LMNA 2320/4885TSHR 1260/4885CYP3A4 567/4885 |
| US-20120040378-A1 | Meprobromate Immunoassay | MEP1B, CES2, MEP1A | LMNA 4619/4885TSHR 740/4885CYP3A4 22/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.